New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 and CCR5

2018/29/N/NZ7/00287

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Klaudia Kwiatkowski

Number of co-investigators in the project: 3

Call

PRELUDIUM 15 – announced on 2018-03-15

Amount awarded
209 900 PLN
Project start date
2019-02-06
Project end date
2023-02-05
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Aparat Mini-PROTEAN do poczwórnej pionowej elektroforezy. Cost: 2 600 PLN
  2. Aparat do elektroforezy z wykorzystaniem żeli Criterion. Cost: 2 700 PLN
  3. Ogranicznik dla gryzoni z oświetlaczem ogona do podań dożylnych. Cost: 4 114 PLN

Information in the final report

Publication in academic press/journals (3)

  1. Pharmacological Evidence of the Important Roles of CCR1 and CCR3 and Their Endogenous Ligands CCL2/7/8 in Hypersensitivity Based on a Murine Model of Neuropathic Pain.

    Authors:
    Pawlik K, Ciapała K, Ciechanowska A, Kwiatkowski K, Mika J.
    Academic press:
    Cells (year: 2023, volume: 12, pages: 98), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cells12010098 – link to the publication
  2. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses.

    Authors:
    Kwiatkowski K. Ciapała K., Rojewska E., Makuch W., Mika J.
    Academic press:
    Int Immunopharmacol. (year: 2020, volume: 84, pages: 106540 (1-12)), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.intimp.2020.106540. – link to the publication
  3. Bidirectional action of cenicriviroc, a CCR2/CCR5 antagonist, results in alleviation of pain-related behaviors and potentiation of opioid analgesia in rats with peripheral neuropathy.

    Authors:
    Kwiatkowski K., Pawlik K., Ciapała K., Piotrowska A., Makuch W., Mika J.
    Academic press:
    Front. Immunol. (year: 2020, volume: 11, pages: 615327(1-16)), Publisher: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2020.615327 – link to the publication

Articles in post-conference publications (4)

  1. The dual CCR2/CCR5 antagonist, Cenicriviroc, attenuated neuropathic pain-related behavior and enhanced morphine effectiveness.

    Authors:
    Ciapała K., Kwiatkowski K., Makuch W., Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (year: 2019, pages: 193), Publisher: EFIC
    Date:
    conference 2019-09-4-7
    Status:
    Published
  2. Involvement of chemokines CCL2 and CCL7 in pathogenesis of neuropathic pain in mice.

    Authors:
    Kwiatkowski K., Popiolek-Barczyk K., Rojewska E., Makuch W., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research From Lab to clinic (year: 2019, pages: 30), Publisher: Index Copernicus International
    Date:
    conference 2019-06-22-27
    Status:
    Published
  3. Comparison of analgesic effects of maraviroc, RS504393 and cenicriviroc in rodents after sciatic nerve injury based on behavioral and molecular studies.

    Authors:
    Kwiatkowski K., Ciapała K., Popiołek-Barczyk K., Makuch W., Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (year: 2019, pages: 119), Publisher: EFIC
    Date:
    conference 2019-09-4-7
    Status:
    Published
  4. Czy leki antyretrowirusowe mogą działać przeciwbólowo? Rola CCR5 w bólu neuropatycznym.

    Authors:
    Kwiatkowski K., Ciapała K., Popiolek-Barczyk K., Piotrowska A., Makuch W., Mika J.
    Conference:
    X Zjazd Polskiego Towarzystwa Badania Bólu – MEDYCYNA BÓLU 2019 (year: 2019, pages: 63), Publisher: Index Copernicus International
    Date:
    conference 2019-09-26-28
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski